CellBion Co., Ltd. (KOSDAQ:308430)
South Korea
· Delayed Price · Currency is KRW 26,100
+50 (0.19%)
At close: Dec 5, 2025
CellBion Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2016 |
| Operating Revenue | 2,130 | 2,290 | 1,471 | 1,763 | 916.88 | 1,361 | Upgrade
|
| Other Revenue | -0 | -0 | - | - | - | - | Upgrade
|
| Revenue | 2,130 | 2,290 | 1,471 | 1,763 | 916.88 | 1,361 | Upgrade
|
| Revenue Growth (YoY) | -2.44% | 55.64% | -16.54% | 92.27% | -32.61% | 288.80% | Upgrade
|
| Cost of Revenue | 2,059 | 1,327 | 1,162 | 1,559 | 1,044 | 1,339 | Upgrade
|
| Gross Profit | 70.73 | 963.28 | 309.04 | 203.57 | -126.94 | 21.62 | Upgrade
|
| Selling, General & Admin | 2,323 | 2,099 | 1,263 | 2,443 | 2,017 | 1,619 | Upgrade
|
| Research & Development | 4,894 | 5,295 | 3,426 | 2,976 | 2,340 | 1,403 | Upgrade
|
| Amortization of Goodwill & Intangibles | 75.32 | 72.29 | 70.9 | - | - | - | Upgrade
|
| Other Operating Expenses | 143.88 | 118.08 | 92.58 | 87.86 | 66.61 | 56.73 | Upgrade
|
| Operating Expenses | 7,989 | 8,100 | 5,352 | 5,507 | 4,423 | 3,079 | Upgrade
|
| Operating Income | -7,919 | -7,137 | -5,043 | -5,303 | -4,550 | -3,057 | Upgrade
|
| Interest Expense | -91.1 | -129.87 | -140.18 | -352.51 | -276.8 | -137.02 | Upgrade
|
| Interest & Investment Income | 881.03 | 363.22 | 74.81 | 124.2 | 36.07 | 13.28 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.54 | -0.92 | - | -0.13 | 0.01 | -0.04 | Upgrade
|
| Other Non Operating Income (Expenses) | -426.59 | -363.18 | 202.5 | -1,014 | 13.34 | 141.89 | Upgrade
|
| EBT Excluding Unusual Items | -7,555 | -7,267 | -4,906 | -6,546 | -4,778 | -3,039 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.03 | 1.29 | 9.89 | - | -0 | - | Upgrade
|
| Other Unusual Items | - | - | 1,263 | 164.1 | - | - | Upgrade
|
| Pretax Income | -7,555 | -7,266 | -3,633 | -6,382 | -4,778 | -3,039 | Upgrade
|
| Net Income | -7,555 | -7,266 | -3,633 | -6,382 | -4,778 | -3,039 | Upgrade
|
| Net Income to Common | -7,555 | -7,266 | -3,633 | -6,382 | -4,778 | -3,039 | Upgrade
|
| Shares Outstanding (Basic) | - | 10 | 10 | 10 | 9 | 9 | Upgrade
|
| Shares Outstanding (Diluted) | - | 10 | 10 | 10 | 9 | 9 | Upgrade
|
| Shares Change (YoY) | - | 2.34% | 2.22% | 10.36% | 1.48% | 0.97% | Upgrade
|
| EPS (Basic) | - | -715.78 | -366.24 | -657.64 | -543.34 | -350.74 | Upgrade
|
| EPS (Diluted) | - | -715.78 | -366.24 | -658.00 | -543.34 | -351.00 | Upgrade
|
| Free Cash Flow | -6,509 | -4,904 | -4,240 | -5,074 | -3,572 | -2,380 | Upgrade
|
| Free Cash Flow Per Share | - | -483.08 | -427.43 | -522.88 | -406.23 | -274.73 | Upgrade
|
| Gross Margin | 3.32% | 42.07% | 21.00% | 11.55% | -13.84% | 1.59% | Upgrade
|
| Operating Margin | -371.79% | -311.67% | -342.79% | -300.83% | -496.28% | -224.69% | Upgrade
|
| Profit Margin | -354.71% | -317.32% | -246.92% | -362.02% | -521.08% | -223.36% | Upgrade
|
| Free Cash Flow Margin | -305.59% | -214.16% | -288.18% | -287.84% | -389.58% | -174.95% | Upgrade
|
| EBITDA | -7,256 | -6,512 | -4,426 | -4,944 | -3,900 | -2,381 | Upgrade
|
| EBITDA Margin | - | -284.37% | - | -280.44% | - | -175.00% | Upgrade
|
| D&A For EBITDA | 662.5 | 625.05 | 617.69 | 359.53 | 650.52 | 676.09 | Upgrade
|
| EBIT | -7,919 | -7,137 | -5,043 | -5,303 | -4,550 | -3,057 | Upgrade
|
| EBIT Margin | - | - | - | - | - | -224.69% | Upgrade
|
| Advertising Expenses | - | 5.27 | 6.23 | 7.57 | 7.85 | 3.77 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.